We are excited to announce that Glycanostics placed third in Vodafone’s Idea of the Year 2018 competition, a prestigious event for early-stage startups. The competition's objectives are to actively support innovative projects with high market potential by providing mentoring, mediating investments worth up to CZK 10 million, internationalizing projects, and establishing beneficial contacts. It's the oldest startup competition in the Czech Republic, and each year new features are added to open additional opportunities to its participants.
Tomas Bertok, Co-Founder of Glycanostics Ltd. comments:
“We'd like to thank the organizers for such an amazing event! It was very exciting to become a finalist competing with over 200 innovative startups. And, of course, it’s very encouraging when experienced entrepreneurs, investors and media professionals in the jury see the global potential of our project. We are definitely on the right track and are going to move, step by step, to bring our innovation to the market and help thousands of people worldwide to avoid cancer misdiagnosis!”
Another great experience within this competition was Mentoring Day. All mentors personally dedicated themselves to ten finalists and gave them valuable advice in areas such as strategy, sales, finance, and technology. The mentoring day was full of feedback discussions and special, intensive workshops focused on sales and financial management.
Vodafone Idea of the Year competition has already distributed over CZK 60 million in investments among interesting business projects and early-stage start-ups. There are three competition categories with awards: The “Best Registered Project” in the main Vodafone Idea of the Year category, the “Student Project with the Greatest Potential” in the Ekonom Student Entrepreneur category, and the “Best Technological Project” in the Coolpad Startup of the Year category.
ESET launched a prestigious ESET Science Award for exceptional scientists
Means and methods for glycoprofiling of a protein
Glycanostics successfully finished the first phase of SME Instrument
After receiving the prestigious “Seal of Excellence” on October 23, the next submission to the Horizon 2020 Programme, won a € 50 000 grant.
This project received the highest scores for its proposal in the extremely competitive evaluation process.
Glycanostics was chosen as a finalist in the Grand Finale with five other remarkable startups.
The application covering Glycanostics' diagnostic method is currently filed in two patent offices in Europe and Luxemburg.
Glycanoctics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant.
In April 2018 the technology validation was successfully completed indicating a great potential of Glycanostics innovative products for prostate cancer (PCa) diagnostics.
Glycanostics is an innovative start-up company established in 2017 to bring its revolutionary cancer diagnostics products to the US and EU markets.